Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC – IFCT 02-01

P Fournel,H Lena,Radj Gervais,Herve Le Caer, Mariececile Bozonnat,Jeanpierre Daures,Jeannoel Talabard,Alain Vergnenegre, B Melloni,C Decroisette,P Clavere,G Robinet, Sophie Bayle,Jean Philippe Labat, C Belleguic,M Benchalal,A Riviere, D Lerouge,P J Souquet, L Geriniere, A Dhombres, F Mornex,H Le Caer, E Tessier, H Ramos, J M Chavaillon,C Chouaid,E Touboul,S Bota,L Thiberville, O Gallocher, E Quoix, B Mennecier, G M Jung,Lionel Falchero,D Paillotin, S Schouabe, E Jonveaux, J C Bout, Paul J Martin,Maurice Perol, D Arpin,Isabelle Martellafay, J Letreut,Roland Poirier, A Benyoub, J M Vernejoux, R Trouette,E Dansin, H Berard, Jeanclaude Pietra,G Zalcman, P Thomas, A Zribi,B Milleron, A Lavole, D Coetmeur, Bruno Lamezec, C Bonnamour, V Grangeon, J P Suchaud,Jacky Crequit, S Ramdane, P Barre, M A Zawadi,Celine Gimenez,Fabrice Barlesi, T Pignon, M Grivaux,F Blanchon, J Mandet, D Perdu, Adela Cauchois, J Y Delhoume, B Kin,Philippe Merle, H Janicot, Pierre Verrelle,J B Auliac, Y Coscas, A Ducolone, David J Herman, A Roquette

European Journal of Cancer(2016)

引用 20|浏览22
暂无评分
摘要
•Optimal sequencing of radiotherapy and chemotherapy is not well defined for stage III NSCLC.•Cisplatin-based chemotherapy as induction or consolidation of chemoradiotherapy is safe.•Response rates were similar in both arms without difference in survival.
更多
查看译文
关键词
Lung cancer,Radiotherapy,Chemotherapy,Therapeutics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要